Search for a report

Reports

  • You are here:
  • Home
  • Downloads
  • ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET FORECAST 2021-2028

ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET FORECAST 2021-2028

The Asia-Pacific infertility testing & treatment market is evaluated to project a CAGR of 10.90% during the forecasted period. The regional market’s growth is mainly ascribed to key factors such as the accelerated adoption of fertility procedures, the rise in fertility tourism, and the accessibility to affordable treatments.

ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET FORECAST 2021-2028

Asia Pacific Infertility Testing & Treatment Market by Gender ( Male (Male Infertility Testing ( Dna Fragmentation, Oxidative Stress Analysis, Sperm Penetration Assay, Computer-assisted Semen Analysis (Casa), Sperm Agglutination, Microscopic Examination, Others ) Male Infertility Treatment (Medication, Assisted Reproductive Technology & Varicocele Surgery)) (Female ( Female Infertility Testing ( Ovulation Testing, Hysterosalpingography, Laparoscopy, Transvaginal Ultrasound, Ovarian Reserve Testing, Hormonal Level Testing, Others) Female Infertility Treatment ( IVF With ICSI, IUI, IVF Without ICSI, Surrogacy, Others)) Market by End-user ( Fertility and Surgical Centers, Hospitals and Research Laboratories, Cryobanks) and by Geography.

Request free sample

Report Summary

The Asia-Pacific infertility testing & treatment market is evaluated to project a CAGR of 10.90% during the forecasted period. The regional market’s growth is mainly ascribed to key factors such as the accelerated adoption of fertility procedures, the rise in fertility tourism, and the accessibility to affordable treatments.

asia-pacific-infertility-testing-and-treatment-market

The Asia-Pacific infertility testing & treatment market growth assessment constitutes the evaluation of South Korea, India, Vietnam, China, Japan, Indonesia, Australia & New Zealand, Thailand, and the rest of the Asia-Pacific. The changing lifestyle patterns, as well as the trend of delayed pregnancies in China, have resulted in declining fertility rates, thereby driving the need for IVF treatments. Moreover, the lower cost of IVF treatment further facilitates the country’s market growth. As per a joint survey by the China Population Association and the China Woman and Child Development Center, the fertility rate in China is gradually decreasing.

On the other hand, developed healthcare infrastructure, lower birth rates, the availability of technologically advanced IVF treatments, and declining fertility rates play a vital role in fuelling the market growth in Japan. The Pharmaceuticals & Medical Devices Agency (PMDA) as well as The Ministry of Health, Labor and Welfare (MHLW) primarily regulate the country’s critical endeavors, including the distribution, production, and export of IVF devices. Thus, the abovementioned factors are anticipated to influence the market growth in the Asia-Pacific over the forecast period.

Bangkok IVF Center, headquartered in Thailand, offers solutions for infertility treatments or preimplantation genetic diagnosis (PGD). It operates as a part of the BNH International Hospital, Silom, by a Group of Bangkok Infertility scientists and specialists. The company provides fertility services such as surgical sperm retrieval, ovulation induction, IVF, oocyte retrieval, blastocyst transfer, sperm analysis, assisted hatching, and others.

 

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


    Table of Contents

    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • MARKET OVERVIEW
    3. MARKET DYNAMICS
      • KEY DRIVERS
        • GROWING STRESS AND LIFESTYLE DISORDERS
        • INCREASED AGE OF CONCEPTION
        • INCREASING EFFECTIVENESS OF TREATMENTS
        • RISING GOVERNMENT SUPPORT
      • KEY RESTRAINTS
        • HIGH COST OF TESTING AND TREATMENT
        • INFERTILITY CONSIDERED A SOCIAL TABOO
        • POSSIBLE RISKS ASSOCIATED WITH INFERTILITY TREATMENTS
    1. KEY ANALYTICS
      • IMPACT OF COVID-19 ON INFERTILITY TESTING & TREATMENT MARKET
      • KEY MARKET TRENDS
      • PORTER’S FIVE FORCES ANALYSIS
        • BUYERS POWER
        • SUPPLIERS POWER
        • SUBSTITUTION
        • NEW ENTRANTS
        • INDUSTRY RIVALRY
      • OPPORTUNITY MATRIX
      • VENDOR LANDSCAPE
      • KEY BUYING CRITERIA
        • TREATMENT OPTIONS
        • QUALITY OF MEDICAL PROCEDURES
        • PRICE OF TREATMENTS
        • SHIFT TOWARDS MEDICAL TOURISM
        • REIMBURSEMENT
      • VALUE CHAIN ANALYSIS
        • RAW MATERIAL PROCUREMENT
        • MANUFACTURING
        • SUPPLY LOGISTICS
        • DISTRIBUTION CHANNELS
        • END-USERS
    1. MARKET BY GENDER
      • MALE
        • MALE INFERTILITY TESTING
          • DNA FRAGMENTATION
          • OXIDATIVE STRESS ANALYSIS
          • SPERM PENETRATION ASSAY
          • COMPUTER-ASSISTED SEMEN ANALYSIS (CASA)
          • SPERM AGGLUTINATION
          • MICROSCOPIC EXAMINATION
          • OTHERS
        • MALE INFERTILITY TREATMENT
          • MEDICATION
          • ASSISTED REPRODUCTIVE TECHNOLOGY & VARICOCELE SURGERY
      • FEMALE
        • FEMALE INFERTILITY TESTING
          • OVULATION TESTING
          • HYSTEROSALPINGOGRAPHY
          • LAPAROSCOPY
          • TRANSVAGINAL ULTRASOUND
          • OVARIAN RESERVE TESTING
          • HORMONAL LEVEL TESTING
          • OTHERS
        • FEMALE INFERTILITY TREATMENT
          • IVF WITH ICSI
          • IUI
          • IVF WITHOUT ICSI
          • SURROGACY
          • OTHERS
    1. MARKET BY END-USER
      • FERTILITY AND SURGICAL CENTERS
      • HOSPITALS AND RESEARCH LABORATORIES
      • CRYOBANKS
    2. GEOGRAPHICAL ANALYSIS
      • ASIA-PACIFIC
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • CHINA
          • JAPAN
          • INDIA
          • SOUTH KOREA
          • INDONESIA
          • THAILAND
          • VIETNAM
          • AUSTRALIA & NEW ZEALAND
          • REST OF ASIA-PACIFIC
    1. COMPETITIVE LANDSCAPE
      • KEY STRATEGIC DEVELOPMENTS
        • MERGERS & ACQUISITIONS
        • PRODUCT LAUNCHES & DEVELOPMENTS
        • PARTNERSHIP & AGREEMENTS
      • COMPANY PROFILES
        • ADORFEM
        • BANGKOK IVF CENTER
        • COOK MEDICAL INC
        • COOPER SURGICAL
        • CREATE FERTILITY CENTRE
        • EMD GROUP (MERCK KGAA)
        • ENDO INTERNATIONAL PLC
        • ESCO MEDICAL
        • FERRING PHARMACEUTICALS
        • FERTILITY FIRST
        • FUJIFILM IRVINE SCIENTIFIC
        • GENEA LTD
        • HALOTECH DNA
        • HAMILTON THRONE LTD
        • IVFTECH
        • LABOTECT GMBH
        • OLYMPUS CORPORATION
        • PROGYNY
        • THERMO FISHER SCIENTIFIC INC
        • VITROLIFE AB

     

    LIST OF TABLES

    TABLE 1: MARKET SNAPSHOT – INFERTILITY TESTING & TREATMENT

    TABLE 2: AVERAGE COST COMPARISON OF INFERTILITY TREATMENTS

    TABLE 3: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY GENDER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 4: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY GENDER, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 5: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY MALE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 6: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY MALE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 7: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY MALE INFERTILITY TESTING, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 8: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY MALE INFERTILITY TESTING, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 9: PROS AND CONS OF DNA SHARING METHODS

    TABLE 10: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY MALE INFERTILITY TREATMENT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 11: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY MALE INFERTILITY TREATMENT, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 12: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE INFERTILITY TESTING, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 13: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE INFERTILITY TESTING, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 14: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE INFERTILITY TREATMENT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 15: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE INFERTILITY TREATMENT, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 16: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 17: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 18: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 19: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 20: LIST OF MERGERS & ACQUISITIONS

    TABLE 21: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

    TABLE 22: LIST OF PARTNERSHIPS & AGREEMENTS

    LIST OF FIGURES

    FIGURE 1: KEY MARKET TRENDS

    FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

    FIGURE 3: OPPORTUNITY MATRIX

    FIGURE 4: VENDOR LANDSCAPE

    FIGURE 5: KEY BUYING CRITERIA

    FIGURE 6: VALUE CHAIN ANALYSIS

    FIGURE 7: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY GENDER, IN 2020

    FIGURE 8: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY MALE, 2021-2028 (IN $ MILLION)

    FIGURE 9: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY MALE, IN 2020

    FIGURE 10: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY MALE INFERTILITY TESTING, 2021-2028 (IN $ MILLION)

    FIGURE 11: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY MALE INFERTILITY TESTING, IN 2020

    FIGURE 12: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY DNA FRAGMENTATION, 2021-2028 (IN $ MILLION)

    FIGURE 13: CAUSES OF SPERM DNA FRAGMENTATION

    FIGURE 14: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY OXIDATIVE STRESS ANALYSIS, 2021-2028 (IN $ MILLION)

    FIGURE 15: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY SPERM PENETRATION ASSAY, 2021-2028 (IN $ MILLION)

    FIGURE 16: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY COMPUTER-ASSISTED SEMEN ANALYSIS (CASA), 2021-2028 (IN $ MILLION)

    FIGURE 17: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY SPERM AGGLUTINATION, 2021-2028 (IN $ MILLION)

    FIGURE 18: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY MICROSCOPIC EXAMINATION, 2021-2028 (IN $ MILLION)

    FIGURE 19: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY OTHERS, 2021-2028 (IN $ MILLION)

    FIGURE 20: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY MALE INFERTILITY TREATMENT, 2021-2028 (IN $ MILLION)

    FIGURE 21: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY MALE INFERTILITY TESTING, IN 2020

    FIGURE 22: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY MEDICATION, 2021-2028 (IN $ MILLION)

    FIGURE 23: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY ASSISTED REPRODUCTIVE TECHNOLOGY & VARICOCELE SURGERY, 2021-2028 (IN $ MILLION)

    FIGURE 24: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE, 2021-2028 (IN $ MILLION)

    FIGURE 25: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY FEMALE, IN 2020

    FIGURE 26: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE INFERTILITY TESTING, 2021-2028 (IN $ MILLION)

    FIGURE 27: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY FEMALE INFERTILITY TESTING, IN 2020

    FIGURE 28: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY OVULATION TESTING, 2021-2028 (IN $ MILLION)

    FIGURE 29: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY HYSTEROSALPINGOGRAPHY, 2021-2028 (IN $ MILLION)

    FIGURE 30: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY LAPAROSCOPY, 2021-2028 (IN $ MILLION)

    FIGURE 31: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY TRANSVAGINAL ULTRASOUND, 2021-2028 (IN $ MILLION)

    FIGURE 32: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY OVARIAN RESERVE TESTING, 2021-2028 (IN $ MILLION)

    FIGURE 33: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY HORMONAL LEVEL TESTING, 2021-2028 (IN $ MILLION)

    FIGURE 34: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY OTHERS, 2021-2028 (IN $ MILLION)

    FIGURE 35: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE INFERTILITY TREATMENT, 2021-2028 (IN $ MILLION)

    FIGURE 36: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY FEMALE INFERTILITY TREATMENT, IN 2020

    FIGURE 37: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY IVF WITH ICSI, 2021-2028 (IN $ MILLION)

    FIGURE 38: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY IUI, 2021-2028 (IN $ MILLION)

    FIGURE 39: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY IVF WITHOUT ICSI, 2021-2028 (IN $ MILLION)

    FIGURE 40: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY SURROGACY, 2021-2028 (IN $ MILLION)

    FIGURE 41: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY OTHERS, 2021-2028 (IN $ MILLION)

    FIGURE 42: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY END-USER, IN 2020

    FIGURE 43: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY FERTILITY AND SURGICAL CENTERS, 2021-2028 (IN $ MILLION)

    FIGURE 44: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY HOSPITALS AND RESEARCH LABORATORIES, 2021-2028 (IN $ MILLION)

    FIGURE 45: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, BY CRYOBANKS, 2021-2028 (IN $ MILLION)

    FIGURE 46: ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

    FIGURE 47: CHINA INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 48: JAPAN INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 49: INDIA INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 50: SOUTH KOREA INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 51: INDONESIA INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 52: THAILAND INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 53: VIETNAM INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 54: AUSTRALIA & NEW ZEALAND INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 55: REST OF ASIA-PACIFIC INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)

    Segmentation

    1. MARKET BY GENDER
      • MALE
        • MALE INFERTILITY TESTING
          • DNA FRAGMENTATION
          • OXIDATIVE STRESS ANALYSIS
          • SPERM PENETRATION ASSAY
          • COMPUTER-ASSISTED SEMEN ANALYSIS (CASA)
          • SPERM AGGLUTINATION
          • MICROSCOPIC EXAMINATION
          • OTHERS
        • MALE INFERTILITY TREATMENT
          • MEDICATION
          • ASSISTED REPRODUCTIVE TECHNOLOGY & VARICOCELE SURGERY
      • FEMALE
        • FEMALE INFERTILITY TESTING
          • OVULATION TESTING
          • HYSTEROSALPINGOGRAPHY
          • LAPAROSCOPY
          • TRANSVAGINAL ULTRASOUND
          • OVARIAN RESERVE TESTING
          • HORMONAL LEVEL TESTING
          • OTHERS
        • FEMALE INFERTILITY TREATMENT
          • IVF WITH ICSI
          • IUI
          • IVF WITHOUT ICSI
          • SURROGACY
          • OTHERS
    1. MARKET BY END-USER
      • FERTILITY AND SURGICAL CENTERS
      • HOSPITALS AND RESEARCH LABORATORIES
      • CRYOBANKS
    2. GEOGRAPHICAL ANALYSIS
      • ASIA-PACIFIC
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • CHINA
          • JAPAN
          • INDIA
          • SOUTH KOREA
          • INDONESIA
          • THAILAND
          • VIETNAM
          • AUSTRALIA & NEW ZEALAND
          • REST OF ASIA-PACIFIC

    Request Free Sample

    To request a free sample copy of this report, please complete the form below :
    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


      Choose License Type

      RELATED REPORTS

      Author: shalini amarnani